title: Further thoughts about the ILLUMINATE studies of tabalumab in SLE.
authors.forename: David
authors.initials: D
authors.lastname: Isenberg
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D053264:B-Cell Activating Factor / Q000037:antagonists & inhibitors*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D053264:B-Cell Activating Factor
keywords: Corticosteroids; Systemic Lupus Erythematosus; Treatment